| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Alzheimer Disease | |||||
| Psychomotor Agitation | |||||
| 2 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Delirium, Dementia, Amnestic, Cognitive Disorders | |||||
| Dementia | |||||
| Dyskinesias | |||||
| Mental Disorders | |||||
| Nervous System Diseases | |||||
| Neurobehavioral Manifestations | |||||
| Neurodegenerative Diseases | |||||
| Neurologic Manifestations | |||||
| Psychomotor Disorders | |||||
| Signs and Symptoms | |||||
| Tauopathies | |||||
| 3 | Interventions listed in this trial | ||||
| prazosin | |||||
| placebo | |||||
| 4 | More general drug interventions related to this trial | ||||
| Adrenergic Agents | |||||
| Adrenergic alpha-Antagonists | |||||
| Adrenergic Antagonists | |||||
| Antihypertensive Agents | |||||
| Cardiovascular Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| University of Washington | |||||
| National Institute on Aging (NIA) | |||||
|
